<table style="border:1px solid #adadad; background-color: #F3F1EC; color: #666666; padding:8px; -webkit-border-radius:4px; border-radius:4px; -moz-border-radius:4px; line-height:16px; margin-bottom:6px;" width="100%">
        <tbody>
                <tr>
                        <td><span style="font-family:Helvetica, sans-serif; font-size:20px;font-weight:bold;">Social Psychology Psychology Headlines Daily Digest (Unofficial)</span></td>
                </tr>
                <tr>
                        <td> </td>
                </tr>
        </tbody>
</table>
<table style="font:13px Helvetica, sans-serif; border-radius:4px; -moz-border-radius:4px; -webkit-border-radius:4px; background-color:#fff; padding:8px; margin-bottom:6px; border:1px solid #adadad;" width="100%">
        <tbody>
                <tr>
                        <td><a href="http://www.socialpsychology.org/client/redirect.php?from=rss_feed&id=182193&url=https://www.upi.com/Health_News/2024/09/03/study-Ozempic-Wegovy-risk-depression-suicide/2591725378190/" style="font-family:Helvetica, sans-serif; letter-spacing:-1px;margin:0;padding:0 0 2px;font-weight: bold;font-size: 19px;line-height: 20px;color:#222;">Ozempic Doesn't Raise Risk of Depression or Suicide, Study Finds</a>
                        <div style="font-family:Helvetica, sans-serif; text-align:left;color:#999;font-size:11px;font-weight:bold;line-height:15px;">Sep 3rd 2024, 08:35</div>

                        <div style="font-family:Helvetica, sans-serif; color:#494949;text-align:justify;font-size:13px;">
                        <p><div><p>Source: <a href="http://www.upi.com/Health_News/" rel="tag" target="_blank">United Press International - Health News</a></p>The popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy. But a new study, published Tuesday in JAMA Internal Medicine, casts doubt on at least one possible problem: the drug does not appear to raise a person's risk of depression or suicide. The study—funded by Novo Nordisk, maker of Ozempic and Wegovy—reviewed data from more than 3,500 people across four...</div><h6></h6><br><a href="https://www.socialpsychology.org/client/redirect.php?action=rssHomepage" target="_blank"><img title="Brought to you by Social Psychology Network" alt="Brought to you by SocialPsychology Network" src="https://www.socialpsychology.org/images/rss-footer-large.png" border="0" width="400" height="45"></a><br><br></p>
                        </div>

                        <div style="font-family:Helvetica, sans-serif; font-size:13px; text-align: center; color: #666666; padding:4px; margin-bottom:2px;"></div>
                        </td>
                </tr>
        </tbody>
</table>
<table style="font:13px Helvetica, sans-serif; border-radius:4px; -moz-border-radius:4px; -webkit-border-radius:4px; background-color:#fff; padding:8px; margin-bottom:6px; border:1px solid #adadad;" width="100%">
        <tbody>
                <tr>
                        <td><a href="http://www.socialpsychology.org/client/redirect.php?from=rss_feed&id=182174&url=https://www.usnews.com/news/us/articles/2024-09-01/california-lawmakers-approve-legislation-to-ban-deepfakes-protect-workers-and-regulate-ai" style="font-family:Helvetica, sans-serif; letter-spacing:-1px;margin:0;padding:0 0 2px;font-weight: bold;font-size: 19px;line-height: 20px;color:#222;">California Lawmakers Approve Bills to Ban Deepfakes and Regulate AI</a>
                        <div style="font-family:Helvetica, sans-serif; text-align:left;color:#999;font-size:11px;font-weight:bold;line-height:15px;">Sep 3rd 2024, 08:35</div>

                        <div style="font-family:Helvetica, sans-serif; color:#494949;text-align:justify;font-size:13px;">
                        <p><div><p>Source: <a href="http://www.usnews.com/" rel="tag" target="_blank">U.S. News and World Report</a></p>California lawmakers approved a host of proposals this week to regulate artificial intelligence, combat deepfakes, and protect workers from exploitation by the rapidly evolving technology. Governor Gavin Newsom has until September 30 to sign the bills, veto them, or let them become law without signature. In July, he signaled support for a proposal to crack down on election deepfakes, but he has also warned that overregulation could hurt the AI...</div><h6></h6><br><a href="https://www.socialpsychology.org/client/redirect.php?action=rssHomepage" target="_blank"><img title="Brought to you by Social Psychology Network" alt="Brought to you by SocialPsychology Network" src="https://www.socialpsychology.org/images/rss-footer-large.png" border="0" width="400" height="45"></a><br><br></p>
                        </div>

                        <div style="font-family:Helvetica, sans-serif; font-size:13px; text-align: center; color: #666666; padding:4px; margin-bottom:2px;"></div>
                        </td>
                </tr>
        </tbody>
</table>
<p><strong>Forwarded by:<br />
Michael Reeder LCPC<br />
Baltimore, MD</strong></p>

<p><strong>This information is taken from free public RSS feeds published by each organization for the purpose of public distribution. Readers are linked back to the article content on each organization's website. This email is an unaffiliated unofficial redistribution of this freely provided content from the publishers. </strong></p>

<p> </p>

<p><s><small><a href="#" style="color:#ffffff;"><a href="https://blogtrottr.com/unsubscribe/565/KZ1tMY">unsubscribe from this feed</a></a></small></s></p>